RxDoctor Payments Data

Karen Bailey, APRN

Family · Murray, KYNPI 1013973528

Payments from drug & device makers

$1,146in general payments, 2019–2025

Across 60 payments — averaging $19.10 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$225
  • Astellas Pharma US Inc$204
  • Lilly USA, LLC$111
  • Novo Nordisk$88
  • AstraZeneca$48
  • Biohaven Pharmaceuticals, Inc.$43
  • plus $426 from 18 others

What the payments were for

  • Food & beverage$1,00588%
  • Education$14112%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,146 in reported general payments places this provider in the 65th percentile of 4,374 family providers in Kentucky.

See all family providers in Kentucky

Medicare billing

Part B allowed, 2024
$64,042
Medicare patients
218
Services billed
1,473

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide70$91,635
EliquisApixaban35$42,939
XareltoRivaroxaban18$28,572
JanuviaSitagliptin Phosphate23$24,332
JardianceEmpagliflozin11$16,568
SynthroidLevothyroxine Sodium104$7,201
NovologInsulin Aspart16$5,389
Lantus SolostarInsulin Glargine,hum.Rec.Anlog28$5,033
Rosuvastatin Calcium346$3,600
Metoprolol Succinate177$2,700
Raloxifene Hcl47$2,585
Levothyroxine Sodium187$2,395
Gabapentin170$2,378
Estradiol (Twice Weekly)Estradiol25$2,207
Albuterol Sulfate HfaAlbuterol Sulfate68$2,120

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic, Novolog$88$97,02386 claims
PfizerEliquis$37$42,93935 claims
AbbVieSynthroid, Armour Thyroid$225$8,393118 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 4,374 family providers in Kentucky.

Other family in Murray

See the full list for Kentucky

Where these figures come from

Is this you, or does something look wrong? →